High-dose radioimmunotherapy/chemotherapy and autologous stem cell transplantation (ASCT) for poor risk and relapsed CD20+non-Hodgkin's lymphoma (NHL): Early feasibility report.

被引：0
作者：
Raubitschek, A
Nademanee, A
Molina, A
Rodriguez, R
White, C
Forman, S
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[2] Idec Pharmaceut Corp, San Diego, CA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5372
引用
收藏
页码：374B / 375B
页数：2
相关论文
共 50 条
[11]   A pilot study of high-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT) in patients with poor risk lymphoma. [J].
Noguera-Irizarry, W ;
Papadopoulos, KP ;
Garvin, J ;
Hesdorffer, CS ;
Nichols, GL ;
Vahdat, LH ;
Donovan, D ;
Diuguid, D ;
Skerrett, D ;
Heitjan, D ;
Lo, KMS ;
Savage, DG .
BLOOD, 2001, 98 (11) :396B-396B
[12]   Long term results of radioimmunotherapy with Bexxar/BEAM and autologous stem cell transplantation (ASCT) for chemotherapy resistant aggressive non-Hodgkin's lymphoma (NHL). [J].
Vose, JM ;
Bierman, PJ ;
Lynch, JC ;
Bociek, GR ;
Jacobs, C ;
Armitage, JO .
BLOOD, 2003, 102 (11) :248A-248A
[13]   High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma [J].
Park, Kwonoh ;
Yoon, Dok Hyun ;
Kim, Shin ;
Park, Chan-Sik ;
Huh, Jooryung ;
Lee, Sang-Wook ;
Suh, Cheolwon .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) :256-262
[14]   High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma [J].
Kwonoh Park ;
Dok Hyun Yoon ;
Shin Kim ;
Chan-Sik Park ;
Jooryung Huh ;
Sang-Wook Lee ;
Cheolwon Suh .
International Journal of Hematology, 2013, 97 :256-262
[15]   High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma [J].
S. Akhtar ;
T. A. M. Elhassan ;
W. Edesa ;
M. S. Rauf ;
M. N. Zahir ;
I. Maghfoor .
Annals of Hematology, 2016, 95 :49-54
[16]   High-dose chemotherapy and autologous stem cell transplantation for relapsed or refractory nodular lymphocyte predominant Hodgkin lymphoma [J].
Akhtar, S. ;
Elhassan, T. A. M. ;
Edesa, W. ;
Rauf, M. S. ;
Zahir, M. N. ;
Maghfoor, I. .
ANNALS OF HEMATOLOGY, 2016, 95 (01) :49-54
[17]   High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults [J].
Greb, A. ;
Bohlius, J. ;
Schiefer, D. ;
Schwarzer, G. ;
Schulz, H. ;
Engert, A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01)
[18]   Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study [J].
Castagna, Luca ;
Magagnoli, Massimo ;
Balzarotti, Monica ;
Sarina, Barbara ;
Siracusano, Licia ;
Nozza, Andrea ;
Todisco, Elisabetta ;
Bramanti, Stefania ;
Mazza, Rita ;
Russo, Filippo ;
Timofeeva, Inna ;
Santoro, Armando .
AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (02) :122-127
[19]   Rituximab and Interleukin 2 (IL2) as treatment for CD20+non-Hodgkin's lymphoma (NHL) following autologous peripheral blood stem cell transplant (ASCT). [J].
Holmberg, LA ;
Maloney, DG ;
Bensinger, WI .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :566S-566S
[20]   High-dose therapy and autologous stem cell transplantation (HDT/ASCT) in relapsed/refractory Hodgkin's lymphoma. Outcome and prognostic factors [J].
Angelopoulou, M. K. ;
Vassilakopoulos, T. P. ;
Tsirkinidis, P. ;
Tsopra, O. ;
Galani, Z. ;
Pappi, V. ;
Moschogiannis, M. ;
Dimitriadou, E. ;
Anargyroy, K. ;
Kalpadakis, C. ;
Masouridis, S. ;
Boutsis, D. ;
Sachanas, S. ;
Dimopoulou, M. ;
Variamis, E. ;
Vyniou, N. -A. ;
Kokoris, S. ;
Siakantaris, M. P. ;
Kyrtsonis, M. -C. ;
Panayiotidis, P. ;
Rombos, Y. ;
Pamgalis, G. A. ;
Beris, P. .
BONE MARROW TRANSPLANTATION, 2010, 45 :S255-S255
12345